C Chang

Violations of 21 Cfr Part 803 - Medical Device Reporting: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$137.21

Violations of 21 Cfr Part 820 Quality System Regulation: Subpart K- Labeling and Packaging Control, Subpart L- Handling, Storage, Distribution, and Installation, Subpart N- Servicing and Subpart O- St

C Chang

$85.59

Violations of 21 Cfr Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$111.20

Violations Of 21 CFR Part 820 Quality System Regulation, Subparts A-B: General Provisions and Quality System Requirements: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$110.66

Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart J Corrective and Preventive Action: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$136.84

Violations of 21 Cfr Part 820 - Quality System Regulation, Subpart C Design Controls: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$127.74

Violations of 21 Cfr Part 806 - Medical Devices; Reports of Corrections and Removals: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$85.59

Violations of 21 Cfr Part 820 - Quality System Regulation, Subpart M Records: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

Out of Stock

Violations of 21 Cfr Part 58 - Good Laboratory Practice for Nonclinical Laboratory: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$85.59

Violations of 21 Cfr Part 56 - Institutional Review Boards: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$86.17

Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart G Production and Process Controls: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$120.08

Violations of 21 Cfr Part 820 Quality System Regulation, Subparts D-F: Document Controls, Purchasing Controls, Identification and Traceability: Warning Letters Issued by U.S. Food and Drug Administrat

C Chang

$102.38

Violations Of 21 CFR Part 820 Quality System Regulation, Subparts H-I: Acceptance Activities and Nonconforming Product: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$127.53

Violations of 21 Cfr Part 812 - Investigational Device Exemptions: Warning Letters Issued by U.S. Food and Drug Administration

C Chang

$137.01